These findings suggest that the suppression of insulin resistance by aliskiren may require the use of higher doses than those used to treat high BP and cardiovascular injury [34], although aliskiren was efficient in renin inhibition in islets, as demonstrated by the observed reductions in ACE and AT1R levels. The gene discussed is REN; the disease is Insulin resistance.